Published in Phys Med Biol on February 07, 2005
On-line target position localization in the presence of respiration: a comparison of two methods. Int J Radiat Oncol Biol Phys (2007) 1.05
Cumulative lung dose for several motion management strategies as a function of pretreatment patient parameters. Int J Radiat Oncol Biol Phys (2009) 0.96
Tumor trailing strategy for intensity-modulated radiation therapy of moving targets. Med Phys (2008) 0.92
A 4D IMRT planning method using deformable image registration to improve normal tissue sparing with contemporary delivery techniques. Radiat Oncol (2011) 0.89
Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Radiat Res (2012) 0.85
Reproducibility of target volumes generated using uncoached 4-dimensional CT scans for peripheral lung cancer. Radiat Oncol (2006) 0.83
Influence of increased target dose inhomogeneity on margins for breathing motion compensation in conformal stereotactic body radiotherapy. BMC Med Phys (2008) 0.78
Optimizing principal component models for representing interfraction variation in lung cancer radiotherapy. Med Phys (2010) 0.77
Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med (1972) 11.51
Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med (1976) 3.22
Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys (1996) 2.70
Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest (1971) 2.67
Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. Phys Med Biol (2000) 2.65
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum (1980) 2.13
Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest (1977) 1.61
Reconsidering the definition of a dose-volume histogram. Phys Med Biol (2005) 1.56
Serum and cerebral spinal fluid complement and serum autoantibodies in systemic lupus erythematosus. Medicine (Baltimore) (1971) 1.52
The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys (2000) 1.52
Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum (1999) 1.43
Real-time tumour-tracking radiotherapy. Lancet (1999) 1.42
Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. J Rheumatol (1997) 1.41
Molecular relationships between two nuclear antigens, ribonucleoprotein and Sm: purification of active antigens and their biochemical characterization. Biochemistry (1981) 1.41
The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum (1986) 1.39
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans. Phys Med Biol (2009) 1.33
Purification and biochemical characterization of nuclear ribonucleoprotein antigen using purified antibody from serum of a patient with mixed connective tissue disease. J Clin Invest (1980) 1.29
Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Autoimmun (1999) 1.28
A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol (1999) 1.24
Detection of lung tumor movement in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys (2001) 1.22
Quantitative assessment of the physical potential of proton beam range verification with PET/CT. Phys Med Biol (2008) 1.19
Mixed connective tissue disease. Bull Rheum Dis (1976) 1.18
Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys (2000) 1.18
Effects of organ motion on IMRT treatments with segments of few monitor units. Med Phys (2007) 1.18
Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis Rheum (1979) 1.16
The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat Res (1999) 1.15
Inference of hysteretic respiratory tumor motion from external surrogates: a state augmentation approach. Phys Med Biol (2008) 1.14
Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell Immunol (1985) 1.11
Cyclophosphamide protection in NZB/NZW disease. Mechanisms and therapeutic regimens. Arthritis Rheum (1976) 1.11
On developing B-spline registration algorithms for multi-core processors. Phys Med Biol (2010) 1.10
The biological effects of anti-thyroid antibodies. Thyroid eosinophilia following passive transfer of anti-thyroglobulin antibody. Immunology (1967) 1.09
Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. Int J Radiat Oncol Biol Phys (2000) 1.08
Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer (2001) 1.06
The reliability of proton-nuclear interaction cross-section data to predict proton-induced PET images in proton therapy. Phys Med Biol (2011) 1.06
Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer (1998) 1.03
Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int J Radiat Oncol Biol Phys (2001) 1.00
Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus. Ann Intern Med (1972) 0.99
Three-dimensional movement of a liver tumor detected by high-speed magnetic resonance imaging. Radiother Oncol (1999) 0.99
Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. Oral Oncol (1999) 0.99
Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J Immunol (1993) 0.98
Anti-tissue antibodies in rheumatic disease: standardization and nomenclature. Arthritis Rheum (1977) 0.97
Early stage head and neck non-Hodgkin's lymphoma. The effect of tumor burden on prognosis. Cancer (1986) 0.96
AI/LEARN/Rheumatology. A comparative study of computer-assisted instruction for rheumatology. Arthritis Rheum (1993) 0.95
Inverse planning for photon and proton beams. Med Dosim (2001) 0.95
AI/RHEUM. A consultant system for rheumatology. J Med Syst (1983) 0.95
Four-dimensional targeting error analysis in image-guided radiotherapy. Phys Med Biol (2009) 0.95
Congenital complete heart block and SSA antibodies: obstetric implications. Am J Obstet Gynecol (1985) 0.94
Human RNA helicase A is a lupus autoantigen that is cleaved during apoptosis. J Immunol (1999) 0.94
IFN-gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids. J Immunol (1998) 0.94
Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer (2013) 0.94
Macroglobulinemia with bone destruction. Am J Med (1968) 0.94
Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum (1990) 0.93
Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens. Arthritis Rheum (1985) 0.93
A hospital-wide PACS: 7 year experience and new development. Comput Methods Programs Biomed (1999) 0.93
Treatment outcome of single or hypofractionated single-isocentric stereotactic irradiation (STI) using a linear accelerator for intracranial arteriovenous malformation. Radiother Oncol (2001) 0.93
The autoimmune antigen Me is distinct and related to undifferentiated connective tissue disease. Arthritis Rheum (1987) 0.93
Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol (1989) 0.93
Characterization of a new antigen-antibody system (Su) in patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.92
High-speed magnetic resonance imaging for four-dimensional treatment planning of conformal radiotherapy of moving body tumors. Int J Radiat Oncol Biol Phys (2000) 0.92
The role of radiotherapy in treating squamous cell carcinoma of the external auditory canal, especially in early stages of disease. Radiother Oncol (2000) 0.91
Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease. Arthritis Rheum (1995) 0.91
Antibodies to nuclear antigens in patients undergoing long-term hemodialysis. Am J Med (1976) 0.91
Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody positive connective tissue disease patients. Arthritis Rheum (1992) 0.91
Intensity modulation with the "step and shoot" technique using a commercial MLC: a planning study. Multileaf collimator. Int J Radiat Oncol Biol Phys (1999) 0.90
Intensity modulated radiotherapy with charged particle beams: studies of inverse treatment planning for rotation therapy. Med Phys (2000) 0.90
Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. J Immunol (2001) 0.90
Teratomas of the central nervous system: treatment considerations based on 34 cases. J Neurosurg (1998) 0.90
Derivation of the tumor position from external respiratory surrogates with periodical updating of the internal/external correlation. Phys Med Biol (2007) 0.90
Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Am J Pathol (1998) 0.90
Interplay effects in proton scanning for lung: a 4D Monte Carlo study assessing the impact of tumor and beam delivery parameters. Phys Med Biol (2013) 0.89
Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation (1983) 0.89
Adoptive transfer murine model of granulomatous experimental autoimmune thyroiditis. Int Rev Immunol (2000) 0.89
A margin model to account for respiration-induced tumour motion and its variability. Phys Med Biol (2008) 0.89
[Dissecting aneurysm of the vertebro-basilar artery--a case report and review of previous cases (author's transl)]. No To Shinkei (1979) 0.89
Number and orientations of beams in intensity-modulated radiation treatments. Med Phys (1997) 0.88
A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis. J Pathol (2008) 0.88
Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system. Clin Immunol Immunopathol (1997) 0.88
Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol (2000) 0.88
Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother Oncol (1998) 0.88
High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix. Radiother Oncol (1998) 0.88
Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin Immunol Immunopathol (1998) 0.87
Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. Am J Cardiol (1991) 0.87
Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum (1991) 0.87
[Inverse radiotherapy planning for intensity modulated photon fields]. Radiologe (1998) 0.87
Conversion of type III pneumococcal polysaccharide low responders to high responders by immunization with a thymus-dependent form of antigen. Cell Immunol (1974) 0.87
Suppression of experimental autoimmune thyroiditis in guinea pigs by pretreatment with thyroglobulin-coupled spleen cells. Cell Immunol (1980) 0.87
Extractable nuclear antigen effect on the DNA anti-DNA reaction and NZB/NZW mouse nephritis. J Clin Invest (1975) 0.87
Extension and validation of an analytical model for in vivo PET verification of proton therapy--a phantom and clinical study. Phys Med Biol (2011) 0.87
Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci (1998) 0.87
High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia. Arthritis Rheum (1988) 0.86
Anatomy of a knowledge-based consultant system: AI/RHEUM. MD Comput (1986) 0.86
Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume. Int J Radiat Oncol Biol Phys (1997) 0.86
The potential and limitations of the inverse radiotherapy technique. Radiother Oncol (1994) 0.86
Correction of scatter in megavoltage cone-beam CT. Phys Med Biol (2001) 0.86